NCT07328087
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07328087
Title COLONYVAQ, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer (COLONYVAQ-CRC)
Acronym COLONYVAQ-CRC
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Biogenea Pharmaceuticals Ltd.
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries GRC

Facility Status City State Zip Country Details
Biogenea Pharmaeuticals Ltd RECRUITING Thessaloniki 54627 Greece Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field